864 1030
[41]
Le´gare´ F, Stacey D, Turcotte S, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev 2014;2014:CD006732.[42
[1_TD$DIFF]
]
Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Counsel 2006;60: 301–12.
[
[2_TD$DIFF]
43]
Stacey D, Samant R, Bennett C. Decision making in oncology: a review of patient decision aids to support patient participation. CA Cancer J Clin. 2008;58:293–304.[
[3_TD$DIFF]
44]
Richard PO, Jewett MA, Bhatt JR, et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol 2015;68:1007–13.
[
[15_TD$DIFF]
45]
Blute ML, Drewry A, Abel EJ. Percutaneous biopsy for risk stratifi- cation of renal masses. Ther Adv Urol 2015;7:265–74.
[
[4_TD$DIFF]
46]
Halverson SJ, Kunju LP, Bhalla R, et al. Accuracy of determining small renal mass management with risk stratified biopsies: confir- mation by final pathology. J Urol 2013;189:441–6.
[
[5_TD$DIFF]
47]
Leppert JT, Hanley J, Wagner TH, et al. Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology 2014;83: 774–80.
[
[16_TD$DIFF]
48]
Rogers CG, Ditlev JA, Tan M, et al. Microarray gene expression profiling using core biopsies of renal neoplasia. Am J Transl Res 2009;1:55–61.
[
[17_TD$DIFF]
49]
Lane BR, Li J, Zhou M, et al. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling. J Urol 2009;181:849–60.
[
[7_TD$DIFF]
50]
Kim SP, Shah ND, Weight CJ, et al. Contemporary trends in nephrec- tomy for renal cell carcinoma in the United States: results from a population based cohort. Int Braz J Urol 2011;37:663.[
[8_TD$DIFF]
51]
Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. Urolo- gist density and county-level urologic cancer mortality. J Clin Oncol 2010;28:2499–504.[
[9_TD$DIFF]
52]
Ahmed S, Shahid RK. Disparity in cancer care: a Canadian perspec- tive. Curr Oncol 2012;19:e376–82.
[
[10_TD$DIFF]
53]
Sanfilippo KM, McTigue KM, Fidler CJ, et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension 2014;63:934–41.[
[11_TD$DIFF]
54]
Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245–57.
[
[12_TD$DIFF]
55]
Reaume MN, Graham GE, Tomiak E, et al. Canadian guideline on genetic screening for hereditary renal cell cancers. Can Urol Assoc J 2013;7:319–23.
[
[13_TD$DIFF]
56]
Ho TH, Jonasch E. Genetic kidney cancer syndromes. J Natl Compr Cancer Netw 2014;12:1347–55.
[
[18_TD$DIFF]
57]
Purdue MP, Ye Y, Wang Z, et al. A genome-wide association study of renal cell carcinoma among African Americans. Cancer Epidemiol Biomarkers Prev 2014;23:209–14.
[
[19_TD$DIFF]
58]
Gudmundsson J, Sulem P, Gudbjartsson DF, et al. A common variant at 8q24.21 is associated with renal cell cancer. Nat Commun 2013;4:2776.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 8 6 1 – 8 6 4
864